FR2205309B1 - - Google Patents

Info

Publication number
FR2205309B1
FR2205309B1 FR7339183A FR7339183A FR2205309B1 FR 2205309 B1 FR2205309 B1 FR 2205309B1 FR 7339183 A FR7339183 A FR 7339183A FR 7339183 A FR7339183 A FR 7339183A FR 2205309 B1 FR2205309 B1 FR 2205309B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7339183A
Other versions
FR2205309A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2205309A1 publication Critical patent/FR2205309A1/fr
Application granted granted Critical
Publication of FR2205309B1 publication Critical patent/FR2205309B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
FR7339183A 1972-11-06 1973-11-05 Expired FR2205309B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5105072A GB1445983A (en) 1972-11-06 1972-11-06 Pharmaceutical formulations

Publications (2)

Publication Number Publication Date
FR2205309A1 FR2205309A1 (fr) 1974-05-31
FR2205309B1 true FR2205309B1 (fr) 1976-04-09

Family

ID=10458450

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7339183A Expired FR2205309B1 (fr) 1972-11-06 1973-11-05

Country Status (14)

Country Link
JP (1) JPS577127B2 (fr)
AU (1) AU467532B2 (fr)
BE (1) BE806946A (fr)
CA (1) CA975297A (fr)
CH (1) CH583734A5 (fr)
CY (1) CY940A (fr)
DE (1) DE2355204A1 (fr)
FR (1) FR2205309B1 (fr)
GB (1) GB1445983A (fr)
HK (1) HK1278A (fr)
IL (1) IL43562A (fr)
KE (1) KE2807A (fr)
MY (1) MY7800180A (fr)
ZA (1) ZA738489B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499672A (en) * 1974-02-14 1978-02-01 Wellcome Found Tablet formulation
US4143129A (en) 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
FR2608045B1 (fr) * 1986-12-12 1990-03-02 Chauvin Laboratoires Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975850A (en) * 1955-08-10 1964-11-18 Wellcome Found Xanthine oxidase inhibitors

Also Published As

Publication number Publication date
MY7800180A (en) 1978-12-31
AU467532B2 (en) 1975-12-04
JPS577127B2 (fr) 1982-02-09
KE2807A (en) 1978-02-17
AU6217773A (en) 1975-05-08
IL43562A0 (en) 1974-03-14
FR2205309A1 (fr) 1974-05-31
GB1445983A (en) 1976-08-11
CA975297A (en) 1975-09-30
HK1278A (en) 1978-01-13
BE806946A (fr) 1974-05-06
IL43562A (en) 1976-08-31
DE2355204A1 (de) 1974-05-16
CH583734A5 (fr) 1977-01-14
ZA738489B (en) 1975-02-26
JPS49133517A (fr) 1974-12-21
CY940A (en) 1978-06-23

Similar Documents

Publication Publication Date Title
FR2205309B1 (fr)
BG17668A1 (fr)
BG18195A1 (fr)
BG18235A1 (fr)
BG20486A1 (fr)
BG21123A1 (fr)
BG26824A3 (fr)
CH1332472A4 (fr)
CH320273A4 (fr)
CH545876A (fr)
CH559524A5 (fr)
CH559642A5 (fr)
CH560040A5 (fr)
CH560298A5 (fr)
CH560356A5 (fr)
CH561580A5 (fr)
CH561604A5 (fr)
CH563177A5 (fr)
CH565574A5 (fr)
CH565882A (fr)
CH565971A5 (fr)
CH566412A5 (fr)
CH566556A5 (fr)
CH566595A5 (fr)
CH566613A5 (fr)

Legal Events

Date Code Title Description
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0177, 920507

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0177, 731105

CL Concession to grant licences